BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:China has already entered post-COVID era from late 2020 with f
 ull resumption of work and production. While China is working to give ful
 l play to its huge domestic market\, it is still committed to intercountr
 y cooperation. More and more overseas pharma companies are exploring busi
 ness and partnership opportunities in China\, eager for a share of the bi
 g cake.In the past 3 to 4 years\, industry structure in pharmaceuticals h
 as changed with remarkable shifts in the leader board. Four of the top te
 n players\, including the market leader\, are new entrants. India and Chi
 na are mutual reliable partner especially in pharma industry. For Indian 
 API and finished dosage companies\, internationalization is a common purs
 uit\, and the growing Chinese pharmaceutical market is an opportunity des
 erving to be firmly grasped. Therefore\, it is important to understand Ch
 ina's constantly updated drug registration and review\, approval policies
  and procedures\, and to find local reliable and committed partners to ef
 ficiently expand business.CPhI &amp\; P-MEC China launches the “E-Trade S
 eason” from March - June 2021 to provide the pharmaceutical industry with
  online learning and trading opportunities. This includes months of infor
 mative content and a targeted matchmaking service - delivering over 8 the
 med webinar series and showcasing high-quality pharma suppliers from 4 po
 pular themes. The Sino-India Pharmaceutical Exchange Session will focus o
 n Indian and Chinese pharma market\, building a learning and networking p
 latform and contributing to the advancement of the connection between Ind
 ia &amp\; China.\n\nTOPICS\n\n\n\nDevelopment Trend of China’s API Indust
 ry and Cooperation Prospect with India\n\n\n\n\n\nRequirements and Practi
 cal Procedures of Imported Drug Registration in China\n\n\n\n\n\nDevelopm
 ent of Indian APIs and Generic Drugs in Indian and Chinese Market\n\n\n\n
 \n\nPanel Discussion: Investment\, Deal Making and Partnership Establishm
 ent in China\n\n\n\n\n\nQ&amp\;A\n\n\n\n
DTEND:20210622T170000
DTSTAMP:20260514T163032Z
DTSTART:20210622T150000
LOCATION:\,
SEQUENCE:0
SUMMARY:China has already entered post-COVID era from late 2020 with full 
 resumption of work and production. While China is working to give full pl
 ay to it...
UID:3f4d1d3e-f7fd-4e8f-89d5-03371cd4fa37
END:VEVENT
END:VCALENDAR